Cellular and molecular mechanisms for the initiation and progression of β cell destruction resulting from the collaboration between macrophages and T cells

Autoimmunity

Volumn 27, Issue 2, 1998, Pages 109-122

  Yoon, Ji Won ^a   Jun, Hee Sook ^b   Santamaria, Pere ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b Ajou University   (South Korea)

Author keywords

Beta cell specific autoimmunity; CD4+ T cells; CD8+ T cells; Cytokines; Free radicals; Macrophages; T cell receptors

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; PERFORIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANTIGEN PRESENTATION; AUTOIMMUNITY; CELL DESTRUCTION; CELL INFILTRATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EXPERIMENTAL DIABETES MELLITUS; HELPER CELL; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOGENESIS; PERIPHERAL LYMPHOCYTE; REVIEW; T LYMPHOCYTE;

EID: 0031968921     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939809008041     Document Type: Review

References (131)

1. Bach, J. F. (1995). Insulin-dependent diabetes mellitus as a β cell targeted disease of immunoregulation. J Autoimmun, 8, 439-463.
2. Rossini, A. A., Greiner, D. L., Friedman, H. P. and Mordes, J. P. (1993). Imunopathogenesis of diabetes mellitus. Diabetes Rev, 1, 43-75.
3. Yoon, J. W., Park, Y. H. and Santamaria, P. (1995). Autoimmunity of insulin-dependent diabetes. In: Flatt P. R., Ioannides, C. eds. Drugs, diet and disease. Vol 2: Mechanistic approaches to diabetes. London: Ellis Howard of Simon and Schuster International Group, 57-97.
4. Tisch, R. and McDevitt, H. (1996). Insulin-dependent diabetes mellitus. Cell, 85, 291-297.
5. Marliss, E., Nakhooda, A., Poussier, P. and Simma, A. (1982). The diabetic syndrome of the 'BB' Wistar rat: Possible relevance to type 1 (insulin-dependent) diabetes in man. Diabetologia, 22, 225-232.
6. Rossini, A. A., Mordes, J. P. and Handler, E. S. (1988). Speculations on etiology of diabetes mellitus: Tumbler hypothesis. Diabetes, 37, 257-261.
7. Marliss, E. B, ed. (1983). The Juvenile Diabetes Foundation workshop on spontaneously diabetic BB rat as potential for insight into human juvenile diabetes. Metab Clin Exp, 32(Suppl. 1), 1-166.
8. Like, A. A., Rossini, A. A., Appel, M. C., Guberski, D. L. and Williams, R. M. (1979). Spontaneous diabetes mellitus: Reversal and prevention in the BB/W rat with antiserum to rat lymphocytes. Science, 206, 1421-1423.
9. Like, A. A., Biron, C. A., Weringer, E. J., Byman, K., Sroczynsaki, E. and Guberski, D. L. (1986). Prevention of diabetes in Biobreeding/Worcester rats with monoclonal antibodies that recognize T-lymphocytes or natural killer cells. J Exp Med, 164, 1145-1159.
10. Makino, S., Kunimoto, K., Munaoko, Y., Mizushima, Y., Katagiri, K. and Tochino, Y. (1980). Breeding of a nonobese diabetic strain of mice. Exp Anim, 29, 1-13.
11. Kolb, H., Kantwerk, G., Treichel. U., Kurner. T., Kiesel, U., Hoppe, T., et al. (1986). Prospective analysis of islet lesions in BB rats. Diabetologia, 29(Suppl. 1), A559.
12. Lee, K., Kim, M., Amano, K., Pak, C., Jarworski, M., Mehta, J., et al. (1988). Preferential infiltration of macrophages during early stages of insulitis in diabetesprone BB rats. Diabetes, 37, 1053-1058.
13. Voorbij, H., Jeucken, P., Kabel, P., DeHaan, M. and Drexhage, H. (1989). Dendritic cells and scavenger macrophages in pancreatic islets of prediabetic BB rats. Diabetes, 38, 1623-1629.
14. Walker, R., Bone, A., Cooke, A. and Baird, J. (1988). Distinct macrophage subpopulations in pancreas of prediabetic BB/E rats: Possible role for macrophages in the pathogenesis of IDDM. Diabetes, 37, 1301-1304.
15. Jasen, A., Homo-Delarche, F., Hooijkaas, H., Leenen, P. J., Dardenne, M. and Drexhage, H. A. (1994). Immunohistochemical characterization of monocyte-macrophages and dendritic cells involved in the initiation of insulitis and beta-cell destruction in NOD mice. Diabetes, 43, 667-675.
16. Ziegler, A. G., Erhard, J., Lampeter, E. F., Nagelkerken, L. M. and Standl, E. (1992). Involvement of dendritic cells in early insulitis of BB rats. J Autoimmun, 5, 571-579.
17. Lee, K., Pak, C., Amano, K. and Yoon, J. W. (1988). Prevention of lymphocytic thyroiditis and insulitis in diabetesprone BB rats by the deletion of macrophages. Diabetologia, 31, 400-402.
18. Lee, K., Amano, K. and Yoon, J. W. (1988). Evidence for initial involvement of macrophages in development of insulitis in NOD mice. Diabetes, 37, 989-991.
19. Oschilewski, U., Kiesel, U. and Kolb, H. (1985). Administration of silica prevents diabetes in BB rats. Diabetes, 34, 197-199.
20. Unuaue, E. R. (1984). Antigen-presenting function of the macrophage. Ann Rev Immunol, 2, 395-428.
21. Unuaue, E. R. and Allen, P. M. (1987). The basis for the immunoregulatory role of macrophages and other accessory cells. Science, 236, 551-557.
22. Yoon, J. W., Jun, H. S. and Utsugi, T. (1995). Initiation of autoimmune type 1 diabetes and its possible prevention. In: Baba S, Kaneko T, eds. Diabetes 1994. Amsterdam: Elsevier Scientific Publishers, 116-126.
23. Nagata, M. and Yoon, J. W. (1992). Studies on autoimmunity for initiation of beta cell destruction: IX. Electron microscopic evidence on a distinct difference in the destruction of beta cells between CD4+ and CD8+ T cell clones derived from lymphocytes infiltrating the islets of NOD mice. Diabetes, 41, 998-1008.
24. Ihm, S. H. and Yoon, J. W. (1990). Studies on autoimmunity for the initiation of beta cell destruction: VI. Macrophages are essential for the development of beta cell specific cytotoxic effectors and insulitis in nonobese diabetic (NOD) mice. Diabetes, 39, 1273-1278.
25. Amano, K. and Yoon, J. W. (1990). Studies on autoimmunity for the initiation of beta cell destruction: V. Decrease of macrophage-dependent T-lymphocytes and NK cytotoxicity in silica-treated DP-BB rats. Diabetes, 39, 590-596.
26. Gepts, W. (1981). Islet changes in human diabetes. In: Cooperstein, S. J., Watkins, D., eds. The Islets of Langerhans: Biochemistry, Physiology, and Pathology. New York: Academic Press, 321-356.
27. Foulis, A. K., Liddle, C. N., Farquharson, M. A., Richmond, J. A. and Weir, R. S. (1986). The histopathology of the pancreas in Type 1 (insulin-dependent) diabetes mellitus: A 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia, 29, 267-274.
28. Bottazzo, G. F., Dean, B. M, McNally, J. M., McKay, E. H., Swift, P. G. and Gamble, D. R. (1985). In situ characterization of autoimmune phenomenon and expression of HLA molecules in the pancreas of diabetic insulitis. N Engl J Med. 313, 353-360.
29. Hanninen, A., Jalkanen, S., Salmi. M., Toikkanen, S., Nikolakaros, G. and Simell, O. (1992). Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. J Clin Invest, 90, 1901-1910.
30. Sibley, R. K., Sutherland, D. E., Goetz, F. and Michael, A. F. (1985). Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest, 53, 132-144.
31. Santamaria, P., Nakhleh, R. E., Sutherland, D. E. and Barbosa, J. J. (1992). Isolation and characterization of T lymphocytes infiltrating a human pancreas allograft affected by isletitis and recurrent diabetes. Diabetes, 41, 53-61.
32. Santamaria, P., Lewis, C., Jessurun, J., Sutherland, D. E. and Barbosa, J. J. (1994). Skewed T cell receptor usage and junctional heterogeneity among isletitis αβ and γδ T cells in human type 1 diabetes. Diabetes, 43, 599-606.
33. Like, A. A., Kislauskis, E., Williams, R. M. and Rossini, A. A. (1982). Neonatal thymectomy prevents spontaneous diabetes mellitus in the BB/W rat. Science, 216, 644-646.
34. Like, A. A., Anthony, M., Guberski, D. L. and Rossini, A. A. (1983). Spontaneous diabetes in the BB/W rat: Effects of glucocorticoids, cyclosporin-A and antiserum to rat lymphocytes. Diabetes, 32, 326-330.
35. Koevary, S., Rossini, A. A., Stroller, W. and Chick, W. (1983). Passive transfer of diabetes in the BB/W rat. Science, 220, 727-728.
36. Edouard, P., Hiserodt, J. C., Plamondon, C. and Poussier, P. (1993). CD8+ T cells are required for adoptive transfer of the BB rat diabetic syndrome. Diabetes, 42, 390-397.
37. Miyazaki, A., Hanafusa, T., Yamada, K., Miyagawa, J., Fujino-Kurihara, H., Nakajima, H., et al. (1985). Predominance of T lymphocytes in pancreatic islets and spleen of prediabetic nonobese diabetic (NOD) mice: A longitudinal study, Clin Exp Immunol, 60, 622-630.
38. Koike, T., Itoh, Y., Ishii, T., Takabayashi, K., Maruyama, N., Tomioka, H., et al. (1987). Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice. Diabetes, 36, 539-541.
39. Ogawa, M., Maruyama, T., Hasegawa, T., Kanaya, T., Kobayashi, F., Tochino, Y., et al. (1985). The inhibitory effect of neonatal thymectomy on the incidence of insulitis in nonobese diabetic (NOD) mice. Biomed Res, 6, 103-105.
40. Dardenne, M., Lepault, F., Bendelac, A. and Bach, J. F. (1989). Acceleration of the onset of diabetes in NOD mice by thymectomy at weaning. Eur J Immunol, 19, 889-895.
41. Makino, S., Harada, M., Kishimoto, Y. and Hayashi, Y. (1986). Absence of insulitis and overt diabetes in athymic nude mice with NOD genetic background. Exp Anim, 35, 495-489.
42. Christianson, S. W., Shultz, L. D. and Leiter, E. H. (1993). Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T cells from diabetic versus prediabetic NOD.NON-Thy-1 a donors. Diabetes, 42, 44-55.
43. Mori, Y., Suko, M., Okudaira, H., Matsuba, I., Tsuruoka, A., Sasaki, A., et al. (1986). Preventive effects of cyclosporin on diabetes in NOD mice. Diabetologia, 29, 244-247.
44. Harada, M. and Makino, S. (1986). Suppression of overt diabetes in NOD mice by anti-thymocyte serum or antiThy 1,2 antibody. Exp Anim, 35, 501-504.
45. Shizuru, J. A., Taylor-Edwards, C., Banks, B. A., Gregory, A. K. and Fathman, C. G. (1988). Immunotherapy of the nonobese diabetic mouse: Treatment with an antibody to T helper lymphocytes. Science, 240, 659-662.
46. Hayward, A. R. and Shreiber, M. (1989). Neonatal injection of CD3 antibody into nonobese diabetic mice reduces the incidence of insulitis and diabetes. J Immunol, 143, 1555-1559.
47. Semp, P., Bedossa, P., Richard, M. F., Villa, M. C., Bach, J. F. and Biotard, C. (1991). Anti-alpha/beta T cell receptor monoclonal antibody provides an efficient therapy for autoimmune diabetes in nonobese diabetic (NOD) mice. Eur J Immunol, 21, 1163-1169.
48. Wicker, L. S., Miller, B. J. and Mullen, Y. (1986). Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes, 35, 855-860.
49. Bendelac, A., Carnaud, C., Biotard, C. and Bach, J. F. (1987). Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. J Exp Med, 166, 823-832.
50. Miller, B. J., Appel, M. C., O'Neil, J. J. and Wicker, L. S. (1988). Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J Immunol, 140, 52-58.
51. Haskins, K., Portas, M., Bergman, B., Lafferty, K. and Bradley, B. (1989). Pancreatic islet-specific T cell clones from nonobese diabetic mice. Proc Natl Acad Sci USA, 86, 8000-8004.
52. Haskins, K. and McDuffie, M. (1990). Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. Science, 249, 1433-1436.
53. Reich, E. P., Sherwin, R. S., Kanagawa, O. and Janeway, C. A. (1989). An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes. Nature, 341, 326-328.
54. Nakano, N., Kikutani, H., Nishimoto, H. and Kishimoto, T. (1991). T cell receptor V gene usage of islet beta cell-reactive T cells is not restricted in nonobese diabetic mice. J Exp Med, 173, 1091-1097.
55. Pankewycz, O., Strom, T. B. and Rubin-Kelly, V. E. (1991). Islet-infiltrating T cell clones from nonobese diabetic mice that promote or prevent accelerated onset diabetes. Eur J Immunol, 21, 873-879.
56. Yagi, H., Matsumoto, M., Kunimoto, K., Kawaguchi, J., Makino, S. and Harada, M. (1992). Analysis of the roles of CD4+ and CD8+ T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice. Eur J Immunol, 22, 2387-2393.
57. Bradley, B. J., Haskins, K., LaRosa, F. G. and Lafferty, K. J. (1992). CD8 T cells are not required for islet destruction induced by a CD4+ islet-specific T cell clone. Diabetes, 41, 1603-1608.
58. Nagata, M., Santamaria, P., Kawamura, T., Utsugi, T. and Yoon, J. W. (1994). Evidence for the role of CD8+ cytotoxic T cells in the destruction of pancreatic beta cells in NOD mice. J Immunol, 152, 2042-2050.
59. Daniel, D., Gill, R. G., Schloot, N. and Wegmann, D. (1995). Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur J Immunol, 25, 1056-1062.
60. Reich, E. P., Scaringe, D., Yagi, J., Sherwin, R. S. and Janeway, C. A. (1989). Prevention of diabetes in NOD mice by injection of autoreactive T lymphocytes. Diabetes, 38, 1647-1651.
61. Hayakawa, M., Yokono, K., Nagata, M., Hatamori, N., Ogawa, W., Miki, A., et al. (1991). Morphological analysis of selective destruction of pancreatic beta cells by cytotoxic T lymphocytes in NOD mice. Diabetes, 40, 1210-1217.
62. d monoclonal antibody. Diabetes, 40, 1203-1209.
63. Matsumoto, M., Yagi, H., Kunimoto, K., Kawaguchi, J., Makino, S. and Harada, M. (1993). Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: The roles of T cell subsets in the pathogenesis. Cell Immunol, 148, 1723-1730.
64. Shimizu, J., Kanagawa, O. and Unanue, E. R. (1993). Presentation of beta cell antigens to CD4+ and CD8+ T cells of nonobese diabetic mice. J Immunol, 151, 1723-1730.
65. Wegmann, D., Norbury-Glaser, M. and Daniel, D. (1994). Insulin-specific T cells are a predominant component of islet infiltrates in prediabetic NOD mice. Eur J Immunol, 24, 1853-1857.
66. Bendelac, A., Boitard, C., Bedossa, P., Bazin, H. and Bach, J. F. (1988). Adoptive T cell transfer of autoimmune nonobese diabetic mouse diabetes does not require recruitment of host B-lymphocytes. J Immunol, 141, 2625-2628.
67. Thivolet, C., Bendelac, A., Bedossa, P., Bach, J. F. and Carnaud, C. (1991). CD8+ T cell homing to the pancreas in the nonobese diabetic mouse is CD4+ T cell-dependent. J Immunol, 146, 85-88.
68. Mutchings, P., Rosen, H., O'Reilly, L., Simpson, E., Gordon, S. and Cooke, A. (1990). Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages. Nature, 348, 639-642.
69. Lo, D., Reilly, C., Scott, B., Liblau, R., McDevitt, H. and Burkly, L. (1993). Antigen-presenting cells in adoptively transferred spontaneous autoimmune diabetes. Eur J Immunol, 23, 1693-1698.
70. Katz, J., Benoist, C. and Mathis, D. (1995). T helper cell subsets in insulin-dependent diabetes. Science, 268, 1185-1188.
71. Peterson, J. D. and Haskins, K. (1996). Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones. Differential requirement for CD8 T-cells. Diabetes, 45, 328-336.
72. Haskins, K., Portas, M., Bradley, B., Wegmann, D. and Lafferty, K. (1988). T-lymphocyte clone specific for pancreatic islet antigen. Diabetes, 37, 1444-1448.
73. Katz, J. D., Wang, B., Haskins, K., Benoist, C. and Mathis, D. (1993). Following a diabetogenic T cell from genesis through pathogenesis. Cell, 74, 1089-1100.
74. Katz, J., Benoist, C. and Mathis, D. (1993). Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice. Eur J Immunol, 23, 3358-3360.
75. Wicker, L. S., Leiter, E. H., Todd, J. A., Renjilian, R. J., Peterson. E., Fischer, P. A., et al. (1994). β2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes, 43, 500-504.
76. Santamaria, P., Utsugi, T., Park. B. J., Averill, N., Kawazu, S. and Yoon, J. W. (1995). Beta cell cytotoxic CD8+ T cells from nonobese diabetic mice use highly homologous T cell receptor alpha chain CDR3 sequences. J Immunol, 154, 2494-2503.
77. Wong, S., Visintin, I., Wen, L., Flavell, R. A. and Janeway, C. A. Jr. (1996). CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J Exp Med, 183, 67-76.
78. Utsugi, T., Yoon, J. W., Park, B. J., Imamura, M., Averil, N., Kawazu, S. and Santamaria, P. (1996). Major histocompalibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived β cell cytotoxic CD8+ T cell clones in vivo. Diabetes, 45, 1121-1131.
79. Verdaguer, J., Yoon, J. W., Averill, N., Utsugi, T., Park, B. J. and Santamaria, P. (1996). Acceleration of diabetes in NOD mice expressing beta cell-cytotoxic T cell-derived TcRβ transgene. J Immunol, 157, 4726-4735.
80. Chervonsky, A. V, Wang, Y., Wong, F. S., Visintin, I., Flavell, R. A., Janeway, Jr. C. A., et al. (1997). The role of Fas in autoimmune diabetes. Cell, 89, 17-24.
81. Mandrup-Poulsen, T., Bendtzen, K., Nielsen, J. H., Bendixen, G. and Nerup, J. (1985). Cytokines cause functional and structural damage to isolated islet of Langerhans. Allergy, 40, 424-429.
82. Pankewycz, O. G., Guan, J. X. and Benedict, J. F. (1995). Cytokines as mediators of autoimmune diabetes and diabetic complications. Endocrine Rev, 16, 164-176.
83. Bendtzen, K., Mandrup-Poulsen, T., Nerup, J., Nielsen, J. H., Dinarello, C. A. and Svenson, M. (1986). Cytotoxicity of human p 17 interleukin-1 for pancreatic islets of Langerhans. Science, 232, 1545-1547.
84. Sandler, S., Eizirik, D. L., Svensson, C., Strandell, E., Welsh, M. and Welsh, N. (1991). Biochemical and molecular actions of interleukin-1 on pancreatic β-cells. Autoimmunity, 10, 241-253.
85. Wogensen, L. D., Reimers, J., Mandrup-Poulsen, T. and Nerup, J. (1991). Recombinant human interleukin-1β(IL-1) induces a transient diabetic state in normal rats. Diabetes, 40(Suppl. 1), 117A.
86. Eizirik, D. L., Tracey, D. E., Bendtzen, K. and Sandier, S. (1991). An interleukin-1 receptor antagonist protein protects insulin-producing beta cells against suppressive effects of interleukin-1 beta. Diabetologia, 34, 445-448.
87. Hughes, J. H., Colca, J. R., Easom, R. A., Turk, J. and McDaniel, M. L. (1990). Interleukin 1 inhibits insulin secretion from isolated rat pancreatic islets by a process that requires gene transcription and mRNA translation. J Clin Invest, 86, 856-863.
88. Helqvist, S., Zumsteg, U. W., Spinas, G. A., Palmer, J. P., Mandrup-Poulsen, T., Egeberg, J., et al. (1991). Repetitive exposure of pancreatic islets to interleukin-1β. An in vitro, model of prediabetes? Autoimmunity, 10, 311-318.
89. Mandrup-Poulsen, T., Egeberg, J., Nenip, J., Bendtzen, K., Nielsen, J. H. and Dinarello, C. A. (1987). Ultrastructural studies of time course and cellular specificity of interleukin-1 mediated islet cytotoxicity. Acta Pathol Microbiol Immunol Scand C, 95, 55-63.
90. Mandrup-Poulsen, T., Bendtzen, K., Dinarello, C.A. and Nerup, J. (1987). Human tumour-necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta cell-cytotoxicity. J Immunol, 139, 4077-4082.
91. Southern, D., Schulster, D. and Green, I. C. (1990). Inhibition of insulin secretion by interleukin 1-β and tumor necrosis factor-α via an L-arginine-dependent nitric oxide generation mechanism. FEBS Lett, 276, 42-44.
92. Rabinovitch, A., Pukel, C., Baquerizo, H. and MacKay, P. (1988). Immunological mechanisms of islet βcell destruction. Cytotoxic cells and cytokines. In: Shafrir, E., Reynolds, A. E. eds. Frontiers in Diabetes Research. Lessons from Animal Diabetes II., London: John Libbey and Co., 52-57.
93. Appels, B., Burkart, V., Kantwerk-Funke, M., Funda, J., Kolb-Bachofen, V. and Kolb, H. (1989). Spontaneous cytotoxicity of macrophages against pancreatic islet cells. J Immunol. 142, 3803-3808.
94. Pukel. C., Baquerizo, H. and Rabinovitch, A. (1988). Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of interferon-gamma, tumor necrosis factor, lymphotoxin, and interleukin 1. Diabetes, 37, 133-136.
95. Sandler, S., Bendtzen, K., Eizirik, D.L. and Welsh, M. (1990). Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro. Endocrinol, 126, 1288-1294.
96. Corbett, J. A. and McDaniel, M. L. (1995). Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase. J Exp Med, 181, 559-568.
97. Jiang, Z. and Woda, B. A. (1991). Cytokine gene expression in the islets of the diabetic BioBreeding/Worcester rat. J Immunol, 146, 2990-2994.
98. Welsh, M., Welsh, N., Bendtzen, K., Mares, J., Standell, E., Oberg, C., et al. (1995). Comparison of mRNA contents of interleukin-1β and nitric oxide synthase in pancreatic islets isolated from female and male nonobese diabetic mice. Diabetolagia, 38, 153-160.
99. Trembleau, S., Penna, G., Bosi, E., Mortara, A., Gately, M. K. and Adorini, L. (1995). IL-12 administration induces Th1 cells and accelerates autoimmune diabetes in NOD mice. J Exp Med, 181, 817-821.
100. Zipris, D., Greiner, D. L., Malkani, S., Whalen, B., Mordes, J. P. and Rossini, A. A. (1996). Cytokine gene expression in islets and thyroids of BB rats - IFN-gamma and IL-12p40 mRNA increase with age in both diabetic and insulin-treated nondiabetic BB rats. J Immunol, 156, 1315-1321.
101. Rothe. H., Faust, A., Schade, U., Kleemann, R., Bosse, G., Hibino, T., et al. (1994). Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4. Diabetologia, 37, 1154-1158.
102. Somoza, N., Vargas, F., Roura-Mir, C., Vives-Pi, M., Fernandez-Figueras, M. T., Ariza, A., et al. (1994). Pancreas in recent onset insulin-dependent diabetes mellitus: Changes in HLA, adhesion molecules and autoantigens, restricted T receptor Vβ usage, and cytokine profile. J Immunol, 153, 1360-1372.
103. Berman, M. A., Sandborg, C. I., Wang, Z., Imfeld, K. L., Zaldivar, F. Jr., Dadufalza, V., et al. (1996). Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus. J Immunol, 157, 4690-4696.
104. Rabinovitch, A., Sorenson, O., Suarez-Pinzon, W. L., Power, R. F., Rajotte, R. V. and Bleackley, R. C. (1994). Analysis of cytokine mRNA expression in syngeneic islet grafts of NOD mice: interleukin 2 and Interferon gamma mRNA expression correlates with graft rejection and interleukin 10 with graft survival. Diabetologia, 37, 833-837.
105. Hancock, W. W., Polanski, M., Zhang, J., Blogg, N. and Weiner, B. L. (1995). Suppressioon of insulitis in nonobese diabetic (NOD) mice by oral administration is associated with selective expression of interleukin-4 and - 10, transforming growth factor-β and prostaglandin-E. Am J Pathol, 147, 1193-1199.
106. Tian, J., Atkinson, M. A., Clare-Salzer, M., Hershenfeld, A., Forsthubler, T., Lehmann, P. V., et al. (1996). Nasal administration of glutamate decarboxylase (GAD 65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med, 183, 1561-1567.
107. Kolb, H., Zielasek, J., Treichel, U., Freytag, G., Wrann, M. and Kiesel, U. (1986). Recombinant interleukin-2 enhances spontaneous insulin-dependent diabetes in BB rats. Eur J Immunol, 16, 209-212.
108. Burstein, D., Handler, E. S., Schindler, J., Seals, J., Mordes, J. P. and Rossini, A. A. (1987). Effect of interleukin-2 on diabetes in the BB/Wor rat. Diabetes Res, 5, 163-167.
109. Serreze, D. V., Hamaguchi, K. and Leiter, E. H. (1989). Immunostimulation circumvents diabetes in NOD/Lt mice. J Autoimmun, 2, 759-776.
110. Allison, J., Malcom, L., Chosich, N. and Miller, J. (1992). Inflammation but not autoimmunity occurs in transgenic mice expressing constitutive levels of interleukin-2 in islet beta cells. Eur J Immunol, 22, 1115-1121.
111. Debray-Sachs, M., Carnaud, C., Boitard, C., Cohen, H., Gresser, I., Bedossa, P., et al. (1991). Prevention of diabetes in NOD mice treated with antibody to murine IFN-γ. J Autoimmun, 4, 237-248.
112. Sarvetnick, N., Liggitt, D., Pitts, S., Hansen, S. and Stewart, T. (1988). Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell, 52, 773-782.
113. Hultgren, B., Huang, X., Dybdal, N. and Stewart, T. A. (1996). Genetic absence of γ-interferon delays but does not prevent diabetes in NOD mice. Diabetes, 45, 812-817.
114. Pennline, K. J., Roque-Gaffney, E. and Monahan, M. (1994). Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin Immunol Immunopathol, 71, 169-175.
115. Mueller, R., Krahl, T. and Sarvetnick, N. (1996). Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med, 184, 1093-1099.
116. Rabinovitch, A., Suarez-Pinzon, W., El-Sheikh, A., Sorensen, O. and Power, R. F. (1996). Cytokine gene expression in pancreatic islet-infiltrating leukocytes of BB rats: expression of Th1 cytokines correlates with beta-cell destructive insulitis and IDDM. Diabetes, 45, 749-754.
117. Fox, C. J. and Danska, J. S. (1997). IL-4 expression at the onset of islet inflammation predicts nondestructive insulitis in nonobese diabetic mice. J Immunol, 158, 2414-2424.
118. Wogensen, L., Lee, M. and Sarvetnick, N. (1994). Production of interleukin-10 by islet cells accelerates immune-mediated destruction of β cells in nonobese diabetic mice. J Exp Med, 179, 1379-1384.
119. Asayama, K., Kooy, N. W. and Burr, I. M. (1986). Effect of vitamin E deficiency and selenium deficiency on insulin secretory reserve and free radical scavenging systems in islets; decrease of islet manganosuperoxide dismutase. J Lab Clin Med, 107, 4559-4564.
120. Malaisse, W. J., Malaisse-Lagae, F., Sener, A. and Pipeleers, D. G. (1982). Determinants of the selective toxicity of alloxan to the pancreatic β cell. Proc Natl Acad Sci USA, 79, 927-930.
121. Corbett, J. A. and McDaniel, M. L. (1992). Does nitric oxide mediate autoimmune destruction of β cells? Possible therapeutic interventions in IDDM. Diabetes, 41, 897-903.
122. Faust, A., Kleemann, R., Rothe, H. and Kolb, H. (1996). Role of macrophages and cytokines in β cell death. In: Shafrir E, ed. Lessons from animal diabetes VI. Cambridge: Birkhauser Boston, 1996; 47-56.
123. McDaniel, M. L., Kwon, G., Hill, J. R., Marshall, C. A. and Corbett, J. A. (1996). Cytokines and nitric oxide in islet inflammation and diabetes. Proc Soc Exp Biol Med, 211, 24-32.
124. Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A. and Freeman, B. A. (1990). Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and Superoxide. Proc Natl Acad Sci USA, 87, 1620-1624.
125. Kleemann, R., Rothe, H., Kolb-Bachofen, V., Xie, Q. W., Nathan, C., Martin, S., et al. (1993). Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats. FEBS Lett, 328, 9-12.
126. Linsay, R. M., Smith, W., Rossiter, S. P., McIntyre, M. A., Williams, B. C. and Baird, J. D. (1995). N Omega-nitro-L-arginine methyl ester reduces the incidence of IDDM in BB/E rats. Diabetes, 44. 365-368.
127. Bowman, M., Simell, O., Look, Z., Luchetta, R. and Atkinson, M. (1994). Pharmokinetic and therapeutic analysis of aminoguanidine. Diabetes, 43(Suppl.), 235A.
128. Ko, I. Y., Ihm, S. H. and Yoon, J. W. (1991). Studies on autoimmunity for initiation of beta-cell destruction VIII. Pancreatic beta cell dependent autoantibody to a 38 kilodalton protein precedes the clinical onset of diabetes in BB rats. Diabetologia, 34, 548-554.
129. Ko, I. Y., Jun, H. S., Kim, G. S. and Yoon, J. W. (1994). Studies on autoimmunity for initiation of beta-cell destruction X. Delayed expression of a membrane-bound islet cell-specific 38 kDa autoantigen that precedes insulitis and diabetes in the BB rat. Diabetologia, 37, 460-465.
130. Yoon, J. W. (1995). A new look at viruses in type I diabetes (Invited Review). Diabetes Metab Rev, 11, 83-107.
131. Yoon, J. W. (1996). The role of viruses in the pathogenesis of IDDM. In: Taylor S. L., ed. Diabetes Mellitus: A Fundamental and Clinical Text. Philadelphia: JB Lippincott, 338-348.